Neoepitope detection of disease using protein arrays

Details Neoepitope detection of disease using protein arrays Neoepitope detection of disease using protein arrays

2011-06-21

2011-06-21

Reddig, Peter J (Department: 1642)

Combinatorial chemistry technology: method, library, apparatus

Library, per se

Library containing only organic compounds

C435S007100, C530S300000, C530S324000, C530S327000, C530S328000, C530S329000, C530S330000, C530S350000

Reexamination Certificate

active

07964536

ABSTRACT:
A biosensor for use in detecting the presence of diseases, the biosensor comprising a detector for detecting a presence of at least one marker indicative of a specific disease. A method of determining efficacy of a pharmaceutical for treating a disease or staging disease by administering a pharmaceutical to a sample containing markers for a disease, detecting the amount of at least one marker of the disease in the sample, and analyzing the amount of the marker in the sample, whereby the amount of marker correlates to pharmaceutical efficacy or disease stage. Markers for gynecological disease selected from the list in Table 8. An immuno-imaging agent comprising labeled antibodies, whereby the labeled antibodies are isolated and reactive to proteins overexpressed in vivo. Informatics software for analyzing the arrays of claim1, the software including analyzing means for analyzing the arrays.

REFERENCES:
patent: 2004/0005556 (2004-01-01), Tainsky et al.
Bowie et al (Science, 1990, 257:1306-1310).
Rudikoff et al. (PNAS, USA, 1982, 79: 1979-1983).
Coleman et al. (Research in Immunology, 1994; 145(1): 33-36).
Abaza et al. (Journal of Protein Chemistry, vol. 11, No. 5, 1992, pp. 433-444).
Burgess et al (J. of Cell Biol.1990, 111:2129-2138).
Gura (Science, 1997, 278:1041-1042).
Kaiser (Science, 2006, 313: 1370).
Taber's Cyclopedic Medical Dictionary (1985, F.A. Davis Company, Philadelphia, p. 274).
Busken, C et al. (Digestive Disease Week Abstracts and Itinerary Planner, 2003, abstract No. 850).
Yang et al. (Genome Res. 2001, 11: 1888-1898).
Rast et al. (Developmental Biol. 2000: 228:270-286).
Stone et al. (Int. J. Cancer, Dec. 19, 2002, 104: 73-84).
Alizadeh AA, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511, (2000).
An, A, et al. A learning system for more accurate classifications. Lecture Notes in Artificial Intelligence, Vancouver. 1418:426-441, (1998).
Aunoble B, et al. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer. Int J Oncol 16:567-76, (2000).
Baron AT, et al. Serum sErbB1 and Epidermal Growth Factor Levels As Tumor Biomarkers in Women with Stage III or IV Epithelial Ovarian Cancer Epidemiology. Biomarkers & Prevention 8:129-137, 1999.
Bauer R, et al. Cloning and characterization of theDrosophilahomologue of the AP-2 transcription factor. Oncogene 17:1911-1922 (1998).
Bast RC et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309: 883-887 (1983).
Berek, JS et al. Serum interleukins-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am J Obstet Gynecol 164: 1038-1043 (1991).
Bittner, M et al. Molecular Classification of Cutaneous Malignant Melanoma by Gene Expression Profiling. Nature 406:536-540 (2000).
Boyd J, et al. Hereditary Ovarian Canter: Molecular genetic and clinical implications [Review]. Gynecol Oncol 64:196-206 (1997).
Breiman L, et al. Classification and regression trees, Wadsworth and Brooks (1984).
Buettner R, et al. An alternatively spliced form of AP-2 encodes a negative regulator of transcriptional activation by AP-2. Mol. Cell Biol 13:4174-4185 (1993).
Draghici S. The Constraint Based Decomposition, accepted for publication in Neural Networks, to appear (2001).
Einhorn, N. et al. Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet Gynecol 80:14-18 (1992).
Golub TR, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286:531-537 (1999).
Gotlieb WH, et al. Presence of interleukins in the ascites of patients with ovarian and other intrabdominal cancers. Cytokine 4:385-390 (1992).
Greenlee RT, et al. Cancer Statistics. CA Cancer J Clin 50:7-33 (2000).
Heath, S. et al. Induction of oblique decision tree. In IJCAI-93. Washington, D.C. (1993).
Hogdall EV, et al. Predictive values of serum tumour markers tetranectin, OVX1 , CASA and CA125 in patients with a pelvic mass. Int J serum tumour markers tectranectin, OVX1, CASA and CA125 in patients with a pelvic mass. Int J Cancer 89:519-523 (2000).
Holschneider CH, et al. Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 1:3-10 (2000).
Houts TM: Improved 2-Color Normalization For Microarray Analyses Employing Cyanine Dyes, CAMDA (2000). Critical Assessment of Techniques for Microarray Data Mining. Duke University Medical Center, Dec. 18-19, 2000.
Jacobs IJ, et al. Potential screening tests for ovarian cancer, in Sharp F, Mason WP, Leake RE (eds). Ovarian Cancer. London, Chapman and Hall Medical, 197-205 (1997).
Jacobs, I. et al. Multimodal approach to screening for ovarian cancer. Lancet I 268-271 (1988).
Jacobs I, et al. The CA 125 tumor-associated antigen: a review of the literature. Hum Reprod 4:1-12 (1989).
Kacinski BM et al. Macrophage colony-stimulating factor is produced by human ovarian and endometrial adenocarcinoma-derived cell lines and is present at abnormally high levels in the plasma of ovarian carcinoma patients with active disease. Cancer Cells 7:333-337 (1989).
Kerr, Martin, Churchill. Analysis of variance for gene expression microarray data. Journal of Computational Biology (2000), 7: 819-837.
Kim, SY et al. Coordinate Control of Growth and Cytokeratin 13 Expression by Retinoic Acid. Molecular Carcinogenesis 16:6-11 (1996).
Kohonen T. Learning vector quantization. Neural Networks, 1 (suppl.1):303 (1988).
MacBeath G. et al. Printing proteins as microarrays for high-throughput function determination. Science 289:1760-3 (2000).
Murphy K. On growing better decision trees from data. Unpublished doctoral dissertation. John Hopkins University (1995), p. 1-3, 230-239.
Musavi M. et al. On the training of radial basis functions classifiers. Neural Networks 5:595-603 (1992).
Patsner B. et al. Comparison of serum CA 125 and lipid associated sialic acid (LASA-P) in monitoring patients with invasive ovarian adenocarcinoma. Gynecol Oncol 30(1): 98-103 (1988).
Precup D, et al. Classification using $/Phi$-machines and constructive function approximation. In Proc. 15th International Conf. On Machine Learning, pp. 439-444. Morgan Kaufmann, San Francisco, CA (1998).
Poggio T, et al. Networks for approximation and learning. Proceedings of IEEE 78(9):1481-149 (1990).
Quinlan JR: C4.5: Programs for machine learning, Morgan-Kaufmann (1993), p. 1-27.
Rumelhart, DE, et al. Learning internal representations by error backpropagation. Parallel Distributed Processing: Explorations in the Microstructures of Cognition, MIT Press/Bradford Books (1986).
Schwartz PE, et al. Circulating tumor markers in the monitoring of gynecologic malignancies. Cancer 60:353-361 (1987).
Schmittgen TD et al. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem, 285:194-204 (2000).
Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 1996 77:1501-9.
Nakashima M, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med. 1999 5:938-42.

Affiliated with

Also associated with

Rating

Neoepitope detection of disease using protein arrays does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Neoepitope detection of disease using protein arrays, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neoepitope detection of disease using protein arrays will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2704145